221 results
Page 8 of 12
8-K
EX-99.1
mdd29
7 Jun 06
Other Events
12:00am
424B3
mdawhmg3crod7rr84i
12 May 06
Prospectus supplement
12:00am
8-K
EX-99.1
6zx74j
4 May 06
Discovery Labs Announces Corporate Reorganization and Personnel Reduction
12:00am
8-K
EX-99.1
ovjjct69v9ylzyt385k
26 Apr 06
Discovery Labs Reports Surfaxin Manufacturing Issue
12:00am
8-K
EX-99.1
ze2qqf6k4xhfcv2m
21 Apr 06
Discovery Labs Secures $50 Million Committed Equity Financing Facility
12:00am
8-K
EX-99.1
5cc cmoybiebqxhehl5f
5 Apr 06
Discovery Labs Receives Second Approvable Letter from FDA
12:00am
8-K
EX-99.1
j0u l7tte
31 Mar 06
Discovery Labs Announces Preliminary Results of Phase 2 Clinical Trial in ARDS
12:00am
8-K
EX-99.1
grqz2
1 Mar 06
Discovery Labs Reports Fourth Quarter 2005 Financial Results
12:00am
8-K
EX-99.1
67hws3zh2k0mex
30 Jan 06
Other Events
12:00am
8-K
EX-99.1
v9ft 5qawf0uo
3 Jan 06
Represents strategic decision to control manufacturing of Surfaxinâ and SRT pipeline
12:00am
8-K
EX-99.1
xunxa5
20 Dec 05
Discovery Labs Announces Completion of $20.0 Million Registered Direct Offering
12:00am
8-K
EX-99.1
l0q0xkxnn y3f
14 Dec 05
Discovery Labs to Raise $20.0 Million in Registered Direct Offering
12:00am
8-K
EX-99.1
a7u3efi3mpef41ucg4h
12 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
36uk9py1 8jx
12 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
m98vcf78x d4exp4y0
3 Nov 05
Discovery Labs’ Reports Third Quarter 2005 Financial Results and Business Progress
12:00am
424B5
elf533oe0wqpzoeqd2
28 Oct 05
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
u2s80vy5
21 Oct 05
FDA Accepts Discovery Labs’ Complete Response to
12:00am